期刊
WORLD JOURNAL OF GASTROENTEROLOGY
卷 21, 期 1, 页码 139-154出版社
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.v21.i1.139
关键词
Clarithromycin resistant; Helicobacter pylori; Peptic ulcers; Triple therapy; Treatment
The optimal therapy for Helicobacter pylori (H. pylori) infection should combine a high cure rate and a short treatment duration with a favorable side-effect profile and should maintain a low cost. Several strategies have been proposed to increase the H. pylori eradication rate, including the extension of the treatment duration to 14 d, the use of a four-drug regimen (quadruple, sequential, and concomitant treatments), and the use of novel antibiotics, such as levofloxacin. However, triple therapy remains the most widely accepted first-line treatment regimen in Brazil and the United States and throughout Europe. Because this therapy is limited by resistance to clarithromycin, other therapeutic regimens have been investigated worldwide. This review describes the current literature involving studies directly comparing these different therapies and their efficacies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据